 |
|
"Polypill" Could Slash Diabetes Risks
Bridget M. Kuehn
JAMA. 2006;296:377-380.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Washington—A daily cocktail of inexpensive drugs for individuals with diabetes could save 1.2 million lives, prevent 4.5 million myocardial infarctions, reduce cases of renal failure by 600 000, and result in 1 million fewer cases of blindness or eye surgeries over the next 30 years, said Robert A. Rizza, MD, president of the American Diabetes Association (ADA) at the organization's annual meeting in June.
The proposal for a "polypill" treatment for patients with diabetes was one of a host of presentations at the conference addressing challenges in diabetes care. Physicians and scientists at the meeting emphasized the need to overcome "physician inertia" and encourage all clinicians to treat patients aggressively using the existing arsenal of treatment strategies. They also presented data on genes associated with diabetes, continuous glucose monitoring systems, and treating comorbidities in patients with diabetes or those at risk.
EXISTING TOOLS
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Taking tablets for chronic illness: where next?
Farmer
Chronic Illness 2008;4:235-238.
Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?: Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?
Stirban and Tschoepe
Diabetes Care 2008;31:S226-S228.
ABSTRACT
| FULL TEXT
|
